Literature DB >> 4067430

Relationship of the parameters of body cholesterol metabolism with plasma levels of HDL cholesterol and the major HDL apoproteins.

C B Blum, R B Dell, R H Palmer, R Ramakrishnan, A H Seplowitz, D S Goodman.   

Abstract

The inverse relationship between plasma levels of high density lipoprotein (HDL) and coronary heart disease rates has suggested that HDL might influence body stores of cholesterol. Therefore, we have investigated potential relationships between the parameters of body cholesterol metabolism and the plasma levels of HDL cholesterol and the major HDL apoproteins. The study involved 55 human subjects who underwent long-term cholesterol turnover studies, as well as plasma lipoprotein and apolipoprotein assays. In order to maximize the likelihood of detecting existing relationships, the subjects were selected to span a wide range of plasma levels of lipids, lipoproteins, and apolipoproteins. Single univariate correlation analyses suggested weak but statistically significant inverse relationships of HDL cholesterol and apoA-I levels with the following model parameters: production rate (PR), the mass of rapidly exchanging body cholesterol (M1), the minimum estimate of the mass of slowly exchanging body cholesterol (M3min), and of the mass of total exchangeable body cholesterol (Mtotmin). These correlations, however, were quantitatively quite small (/r/ = 0.28-0.42) in comparison to the strength of the univariate relationships between body weight and PR (r = 0.76), M1 (r = 0.61), M3min (r = 0.58), and Mtotmin (r = 0.78). Correlations for apoA-II and apoE levels were even smaller than those for apoA-I and HDL cholesterol. In additional analyses using multivariate approaches, HDL cholesterol, apoA-I, apoA-II, and apoE levels were all found not to be independent determinants of the parameters of body cholesterol metabolism (/partial r/ less than 0.17, P greater than 0.3 in all cases). Thus the weak univariate correlations reflect relationships of HDL cholesterol and apoA-I levels with physiological variables, such as body size, which are primarily related to the model parameters. We conclude that plasma levels of HDL cholesterol and apoproteins A-I, A-II, and E are not quantitatively important independent determinants of the mass of slowly exchanging body cholesterol or of other parameters of long-term cholesterol turnover in humans. These studies give no support to the hypothesis that the inverse relationship between HDL cholesterol levels and coronary heart disease rates is mediated via an influence of HDL on body stores of cholesterol.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4067430

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Is it time to modify the reverse cholesterol transport model?

Authors:  A R Tall; N Wang; P Mucksavage
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.

Authors:  A R Tall
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

Review 3.  Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.

Authors:  Emil M deGoma; Rolando L deGoma; Daniel J Rader
Journal:  J Am Coll Cardiol       Date:  2008-06-10       Impact factor: 24.094

4.  Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism.

Authors:  I J Goldberg; S Holleran; R Ramakrishnan; M Adams; R H Palmer; R B Dell; D S Goodman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 5.  Plasma lipid concentrations: the concept of "normality" and its implications for detection of high cardiovascular risk.

Authors:  B Lewis
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

6.  2H2O-based high-density lipoprotein turnover method for the assessment of dynamic high-density lipoprotein function in mice.

Authors:  Takhar Kasumov; Belinda Willard; Ling Li; Min Li; Heather Conger; Jennifer A Buffa; Stephen Previs; Arthur McCullough; Stanley L Hazen; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-06-13       Impact factor: 8.311

7.  Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes.

Authors:  Sangeeta R Kashyap; Abdullah Osme; Serguei Ilchenko; Makan Golizeh; Kwangwon Lee; Shuhui Wang; James Bena; Stephen F Previs; Jonathan D Smith; Takhar Kasumov
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

8.  HDL flux is higher in patients with nonalcoholic fatty liver disease.

Authors:  Arthur McCullough; Stephen F Previs; Jaividhya Dasarathy; Kwangwon Lee; Abdullah Osme; Chunki Kim; Serguei Ilchenko; Shuhui W Lorkowski; Jonathan D Smith; Srinivasan Dasarathy; Takhar Kasumov
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-09-10       Impact factor: 4.310

9.  Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice.

Authors:  Tatjana Josefs; Debapriya Basu; Tomas Vaisar; Britt Arets; Jenny E Kanter; Lesley-Ann Huggins; Yunying Hu; Jianhua Liu; Noemie Clouet-Foraison; Jay W Heinecke; Karin E Bornfeldt; Ira J Goldberg; Edward A Fisher
Journal:  Circ Res       Date:  2021-02-03       Impact factor: 17.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.